FDA approves Guidant's implantable defibrillators:
This article was originally published in Clinica
The US FDA has approved Guidant's dual-chamber implantable defibrillator system for treating patients with high defibrillation thresholds. The VENTAK PRZM HE, which is smaller than 40cm(3), is a high output dual-chamber defibrillator. It stores 41 joules of energy and can reliably deliver 35 joules. Guidant also recently received FDA approval for its VENTAK PRIZM 2, a dual-chamber pacemaker/defibrillator.